GE HealthCare Technologies Inc. $GEHC Shares Sold by PNC Financial Services Group Inc.

Posted by Geri Gentry on Jul 26th, 2026

PNC Financial Services Group Inc. cut its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 8.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 187,253 shares of the company’s stock after selling 16,255 shares during the quarter. PNC Financial Services Group Inc.’s holdings in GE HealthCare Technologies were worth $13,329,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in GEHC. Auto Owners Insurance Co grew its stake in GE HealthCare Technologies by 9,525.4% in the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after acquiring an additional 33,629,559 shares during the period. Norges Bank purchased a new stake in GE HealthCare Technologies in the 4th quarter worth $596,024,000. Barrow Hanley Mewhinney & Strauss LLC acquired a new position in GE HealthCare Technologies during the fourth quarter worth $533,655,000. Cynosure Group LLC raised its position in GE HealthCare Technologies by 21,045.4% during the fourth quarter. Cynosure Group LLC now owns 4,365,462 shares of the company’s stock worth $358,055,000 after acquiring an additional 4,344,817 shares during the period. Finally, Boston Partners purchased a new position in GE HealthCare Technologies during the third quarter valued at $287,627,000. 82.06% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

Positive Sentiment: GE HealthCare reported preliminary second-quarter 2026 results and reaffirmed its full-year guidance, which suggests the business is still tracking in line with expectations and may be seeing momentum in key areas. GE HealthCare announces CFO transition; reports preliminary second quarter 2026 financial results and reaffirms guidance reflecting business momentum
Positive Sentiment: The company’s revenue outlook appears steady, with Q2 revenue guidance roughly in line with Wall Street estimates, and management has indicated that second-half performance could improve as cost pressures ease. Can GE HealthCare Sustain Growth in Q2 Amid Persistent Cost Headwinds?
Neutral Sentiment: GE HealthCare announced that CFO Jay Saccaro will step down, but the company framed the move as a transition rather than a crisis, which makes the near-term market impact uncertain. GE HealthCare CFO to step down
Negative Sentiment: Ongoing securities-fraud investigations and shareholder-loss solicitations add legal uncertainty and can weigh on sentiment toward GEHC stock. GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Negative Sentiment: Another law firm expanded a securities-fraud probe tied to prior disclosures, reinforcing investor concerns about possible litigation risk. Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Negative Sentiment: GE HealthCare was downgraded by Zacks Research from “hold” to “strong sell,” which may add to selling pressure. Zacks Research downgrade

Insider Activity at GE HealthCare Technologies

In related news, CFO James Saccaro purchased 3,310 shares of GE HealthCare Technologies stock in a transaction dated Friday, May 1st. The shares were acquired at an average price of $60.60 per share, for a total transaction of $200,586.00. Following the acquisition, the chief financial officer directly owned 87,471 shares in the company, valued at approximately $5,300,742.60. The trade was a 3.93% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Frank R. Jimenez purchased 1,750 shares of the stock in a transaction dated Thursday, April 30th. The shares were purchased at an average cost of $60.45 per share, for a total transaction of $105,787.50. Following the transaction, the insider owned 93,932 shares in the company, valued at approximately $5,678,189.40. The trade was a 1.90% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 21,847 shares of company stock valued at $1,361,355 in the last three months. Company insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Stock Down 2.3%

GEHC stock opened at $60.58 on Friday. The company has a market cap of $27.56 billion, a price-to-earnings ratio of 14.49, a PEG ratio of 1.65 and a beta of 0.72. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77. The firm has a 50-day moving average of $63.63 and a two-hundred day moving average of $71.23.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last issued its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). The company had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, analysts forecast that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be paid a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is 3.35%.

Analysts Set New Price Targets

Several analysts have recently issued reports on GEHC shares. Rothschild & Co Redburn dropped their target price on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research report on Thursday, April 30th. Jefferies Financial Group decreased their price target on shares of GE HealthCare Technologies from $105.00 to $90.00 in a research note on Thursday, April 30th. BMO Capital Markets began coverage on GE HealthCare Technologies in a report on Wednesday, July 8th. They issued a “market perform” rating and a $70.00 price objective on the stock. Weiss Ratings lowered GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 15th. Finally, BTIG Research reissued a “buy” rating and set a $75.00 target price on shares of GE HealthCare Technologies in a report on Monday, July 13th. Ten research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Hold” and an average price target of $76.41.

Read Our Latest Stock Analysis on GE HealthCare Technologies

About GE HealthCare Technologies

(Free Report)

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

Featured Stories

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.